Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1994 1
1997 1
2005 1
2011 1
2012 1
2013 1
2015 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis.
Castillo M, Scott NW, Mustafa MZ, Mustafa MS, Azuara-Blanco A. Castillo M, et al. Cochrane Database Syst Rev. 2015 Jun 1;2015(6):CD009566. doi: 10.1002/14651858.CD009566.pub2. Cochrane Database Syst Rev. 2015. PMID: 26028608 Free PMC article.
The following antihistamines and mast cell stabilisers were evaluated in at least one RCT: nedocromil sodium or sodium cromoglycate, olopatadine, ketotifen, azelastine, emedastine, levocabastine (or levocabastine), mequitazine, bepotastine besilate, combination of antazoline and …
The following antihistamines and mast cell stabilisers were evaluated in at least one RCT: nedocromil sodium or sodium cromoglycate, olopata …
Effects of ocular decongestants.
Abelson MB, Yamamoto GK, Allansmith MR. Abelson MB, et al. Arch Ophthalmol. 1980 May;98(5):856-8. doi: 10.1001/archopht.1980.01020030850009. Arch Ophthalmol. 1980. PMID: 7378008 Clinical Trial.
Mydriatic effect of ocular decongestants studied by pupillography.
Gelmi C, Ceccuzzi R. Gelmi C, et al. Ophthalmologica. 1994;208(5):243-6. doi: 10.1159/000310499. Ophthalmologica. 1994. PMID: 7816414 Clinical Trial.
The mydriatic effect of three ocular decongestants, containing 0.1% tetrahydrozoline hydrochloride, 0.3% chlorpheniramine maleate, and 0.05% tetrahydrozoline hydrochloride in combination with 0.3% pheniramine maleate, respectively, was evaluated in 10 healthy volunt …
The mydriatic effect of three ocular decongestants, containing 0.1% tetrahydrozoline hydrochloride, 0.3% chlorpheniramine maleate, an …
Effects of two eye drop products on computer users with subjective ocular discomfort.
Skilling FC Jr, Weaver TA, Kato KP, Ford JG, Dussia EM. Skilling FC Jr, et al. Optometry. 2005 Jan;76(1):47-54. doi: 10.1016/s1529-1839(05)70254-2. Optometry. 2005. PMID: 15682562 Clinical Trial.
We compared the efficacy and adverse event rates of a new eye lubricant, OptiZen (InnoZen, Inc., polysorbate 80 0.5%) and Visine Original (Pfizer Consumer Healthcare, tetrahydrozoline HCl 0.05%). METHODS: In this double-blind parallel arm trial, 50 healthy men and women, a …
We compared the efficacy and adverse event rates of a new eye lubricant, OptiZen (InnoZen, Inc., polysorbate 80 0.5%) and Visine Original (P …
A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminary results.
Enkvetchakul O, Thanathanee O, Rangsin R, Lekhanont K, Suwan-Apichon O. Enkvetchakul O, et al. Cornea. 2011 Nov;30(11):1213-8. doi: 10.1097/ICO.0b013e31821c9b44. Cornea. 2011. PMID: 21915047 Clinical Trial.
METHODS: In this randomized controlled trial, each primary pterygium patient was randomized to receive either an intralesional injection of bevacizumab 2 mg (1 mg/0.04 mL) or a combination of topical antihistamine (antazoline HCl 0.05%) and vasoconstrictor (tetrahydrozoline …
METHODS: In this randomized controlled trial, each primary pterygium patient was randomized to receive either an intralesional injection of …
Effect of fluorometholone/tetrahydrozoline fixed combination on conjunctival autograft morphology after primary pterygium excision.
Ozgurhan EB, Kara N, Bozkurt E, Gencer B, Agca A, Alkin Z, Demirok A. Ozgurhan EB, et al. Biomed Res Int. 2013;2013:481843. doi: 10.1155/2013/481843. Epub 2013 Jun 20. Biomed Res Int. 2013. PMID: 23865053 Free PMC article. Clinical Trial.
PURPOSE: To evaluate the effect of a fluorometholone/tetrahydrozoline fixed combination on conjunctival graft morphology after primary pterygium excision. ...The conjunctival hyperemia score was significantly lower in the fluorometholone/tetrahydrozoline group compa …
PURPOSE: To evaluate the effect of a fluorometholone/tetrahydrozoline fixed combination on conjunctival graft morphology after primar …